Passage Bio receives Nasdaq delisting notice for bid price below $1.00

Passage BIO, Inc.

Notice received Aug 1, 2024; closing bid price below $1.00 for 30 consecutive days.
180-day compliance period until Jan 28, 2025 to regain minimum $1.00 bid for 10 days.
If not cured, may seek transfer to Nasdaq Capital Market with additional 180-day grace period.
No decisions on response yet; cannot assure regaining compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.